S&P 500 Financials Sector SEC Filings — January 12, 2026

13-01-2026

CompoSecure, Inc. filed an 8-K on January 13, 2026 (AccNo: 0001104659-26-003019, Size: 961 KB), disclosing entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), completion of acquisition or disposition of assets (Item 2.01), creation of direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), changes in certifying accountant (Item 4.01), departure/election of directors/officers and compensatory arrangements (Item 5.02), amendments to articles/bylaws (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific parties, deal structure, valuation, or quantitative details are disclosed in the provided filing summary. All key transaction metrics such as deal size, consideration, and synergies are NOT_DISCLOSED.

13-01-2026

Milestone Pharmaceuticals Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003038, size 190 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

UNITY BANCORP INC /NJ/ filed a Form 8-K on January 13, 2026 (AccNo: 0000920427-26-000004), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure from the US market with no specific quantitative metrics, transaction values, or detailed financial data provided in the filing summary. Sector is not specified.

13-01-2026

Bitcoin Depot Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011043, Size: 183 KB) reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters submitted, vote outcomes, or any numerical results are disclosed in the provided filing summary. This appears to be a mandatory single-item disclosure following a shareholder meeting.

13-01-2026

Offerpad Solutions Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011046, Size: 466 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, or financial impacts disclosed in the provided information.

13-01-2026

Resolute Holdings Management, Inc. filed an 8-K on January 13, 2026 (AccNo: 0001104659-26-003021), disclosing under Item 1.01 entry into a material definitive agreement, Item 2.01 completion of an acquisition or disposition of assets, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 4.01 changes in certifying accountant, and Item 9.01 financial statements and exhibits. No specific details on deal parties, structure, valuation, or quantitative metrics are provided in the filing summary. Sector is not specified.

13-01-2026

EBR Systems, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001214659-26-000377, Size: 238 KB) under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a financial results disclosure from the US market with sector not specified. No specific financial metrics, transaction values, or quantitative data are mentioned.

13-01-2026

D. Boral ARC Acquisition I Corp. filed an 8-K on January 13, 2026 (AccNo: 0001829126-26-000260, Size: 1 MB) disclosing a Merger/Acquisition event with Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Sector not specified. No specific details on parties, deal structure, valuation, or rationale provided in the summary.

13-01-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-001931, Size: 221 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed. Sector is not specified.

13-01-2026

USBC, Inc. disclosed an officer change via Form 8-K filed on January 13, 2026 (AccNo: 0001654954-26-000281, Size: 147 KB) under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or quantitative data provided in the available information. Sector not specified.

13-01-2026

Figure Technology Solutions, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-001929, size 206 KB) under Item 2.02 reporting Results of Operations and Financial Condition. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Inflection Point Acquisition Corp. III filed an 8-K on January 13, 2026 (AccNo: 0001213900-26-003622, Size: 52 MB) disclosing a Merger/Acquisition event under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). Sector not specified. No specific details on parties, structure, valuation, or financial metrics are explicitly stated.

13-01-2026

Ashford Hospitality Trust Inc filed a Form 8-K on January 13, 2026 (AccNo: 0001232582-26-000002, size 499 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item general filing from the US SEC with no sector specified. No core event details, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary.

13-01-2026

BRC Inc. filed an 8-K on January 13, 2026 (AccNo: 0001891101-26-000002, Size: 5 MB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or other specifics are disclosed in the provided filing summary. This appears to be a voluntary disclosure of material information with attached exhibits.

13-01-2026

Energous Corp filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003072, Size: 223 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction values, or quantitative details are disclosed in the provided filing summary. This is a financial results disclosure from the US market.

13-01-2026

Lafayette Digital Acquisition Corp. I filed an 8-K on January 13, 2026 (AccNo: 0001213900-26-003590), disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departure/election of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This filing relates to a merger/acquisition event, but specific parties, deal structure, valuation, or quantitative details are NOT_DISCLOSED in the provided summary. Sector is not specified.

13-01-2026

Momentus Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001140361-26-001016, Size: 365 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.03 (Material Modifications to Rights of Security Holders), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction value, parties, dollar amounts, share counts, or other quantitative metrics are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

CANNAPHARMARX, INC. filed a Form 8-K on January 13, 2026 (AccNo: 0001654954-26-000277, Size: 247 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected officer position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.

13-01-2026

News Corp filed a Form 8-K on January 13, 2026 (AccNo: 0001564708-26-000008, Size: 400 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Delek US Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001886, Size: 3 MB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a general filing from the US SEC with sector not specified. No core event details, financial metrics, transaction values, or other quantitative data are disclosed in the provided filing summary.

13-01-2026

Cardinal Health Inc filed a Form 8-K on January 13, 2026 (AccNo: 0000721371-26-000003, Size: 182 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific details on the core event, transaction, or financial exhibits provided in the summary. No quantitative data, named entities beyond the filer, or material impacts are disclosed.

13-01-2026

Pelican Acquisition Corp filed an 8-K on January 13, 2026 (AccNo: 0001829126-26-000256, Size: 2 MB) announcing a Merger/Acquisition event via Item 7.01 Regulation FD Disclosure, with Item 9.01 providing Financial Statements and Exhibits. No specific details on deal structure, parties involved, valuation, or strategic rationale are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Bank of New York Mellon Corp filed an 8-K on January 13, 2026 (AccNo: 0001390777-26-000004, size: 8 MB) disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing focused on financial results. No specific revenue, earnings, transaction values, or other quantitative metrics are mentioned.

13-01-2026

DOMO, INC. filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001885, Size: 231 KB), reporting entry into a material definitive agreement (Item 1.01), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), and financial statements and exhibits (Item 9.01). No specific details on the agreement, personnel involved, transaction terms, or financial impacts are provided in the summary. Sector is not specified.

13-01-2026

Delta Air Lines, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0000027904-26-000008, Size: 2 MB), reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), and financial statements and exhibits (Item 9.01). No specific details on the agreement, transaction value, financial metrics, or other quantitative data are disclosed in the provided filing summary. This is a multi-item mandatory filing under SEC 8-K requirements.

13-01-2026

JPMorgan Chase & Co filed an 8-K on January 13, 2026 (AccNo: 0001628280-26-001902, Size: 4 MB) reporting financial results under Item 2.02: Results of Operations and Financial Condition and Item 9.01: Financial Statements and Exhibits. This is a multi-item filing for US equity markets via us_sec source. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary.

13-01-2026

uniQure N.V. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003075, Size: 4 MB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure with no specific event details, transaction values, or financial metrics provided in the filing summary. All core event information is NOT_DISCLOSED.

13-01-2026

SONO TEK CORP filed a Form 8-K on January 13, 2026 (AccNo: 0001171520-26-000002, Size: 372 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This discloses financial results. No specific financial metrics, transaction values, or other quantitative data are mentioned.

13-01-2026

Bausch Health Companies Inc. filed an 8-K on January 13, 2026 (AccNo: 0000885590-26-000005, Size: 147 KB) under Items 2.02 (Results of Operations and Financial Condition) and 7.01 (Regulation FD Disclosure). This reports financial results. No specific financial metrics, transaction details, or quantitative data disclosed in the provided filing summary.

13-01-2026

Kymera Therapeutics, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011104, Size: 188 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or other quantitative data are disclosed in the provided filing summary.

13-01-2026

Armata Pharmaceuticals, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003076), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or numerical values are disclosed in the filing summary. Sector is not specified.

13-01-2026

Laird Superfood, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001437749-26-001135, Size: 2 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with sector not specified. No core event details, financial metrics, transaction values, or other quantitative data are explicitly stated.

13-01-2026

Palladyne AI Corp. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011108, Size: 495 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 8.01 (Other Events). This is a multi-item voluntary and mandatory disclosure filing focused on financial results, with no specific numerical financial metrics, transaction values, or detailed outcomes disclosed in the provided summary. Sector not specified.

13-01-2026

Traws Pharma, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003071, Size: 231 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, financial statements, exhibits, transactions, or quantitative impacts are disclosed in the provided filing summary. All transaction values, financial metrics, and strategic details are NOT_DISCLOSED.

13-01-2026

Soluna Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-001945, Size: 344 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This is a general filing with sector not specified.

13-01-2026

Concentrix Corp filed an 8-K on January 13, 2026 (AccNo: 0001803599-26-000003, Size: 652 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. This is a standard financial results disclosure with no further details available.

13-01-2026

Sight Sciences, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011106, Size: 216 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results announcement typical for quarterly or annual earnings disclosures. No specific revenue, earnings, transaction values, or other quantitative financial metrics are disclosed in the provided filing summary.

13-01-2026

Amneal Pharmaceuticals, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001723128-26-000003, Size: 157 KB), disclosing under Item 2.02 Results of Operations and Financial Condition and Item 7.01 Regulation FD Disclosure. This pertains to financial results in the US market, with sector not specified. No specific financial metrics, transaction values, or quantitative data are mentioned in the provided filing summary.

13-01-2026

Actelis Networks Inc filed a Form 8-K on January 13, 2026 (AccNo: 0001213900-26-003681, Size: 237 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events or exhibits are disclosed in the provided filing summary. Sector not specified.

13-01-2026

US BANCORP filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011142, Size: 3 MB), reporting under Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific transaction details, dollar values, or financial metrics disclosed. Sector not specified.

13-01-2026

Acadia Healthcare Company, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001437749-26-001137, Size: 2 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, revenue, earnings, or other quantitative details are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Ichor Holdings, Ltd. filed a Form 8-K on January 13, 2026 (AccNo: 0001652535-26-000004, Size: 166 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure from the US market. No specific financial metrics, transaction values, or quantitative data are mentioned.

13-01-2026

Trinity Capital Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011144, Size: 301 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the nature of the financial statements/exhibits are provided. Sector is not specified.

13-01-2026

Fifth Third Bancorp filed a Form 8-K on January 13, 2026, under Item 8.01 Other Events. Accession Number: 0000035527-26-000011. File size: 752 KB. No details on the specific event, transaction, or financial impacts are disclosed.

13-01-2026

Red Cat Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0000748268-26-000003, Size: 157 KB), reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, transaction values, or other quantitative financial metrics are disclosed in the provided filing summary. This appears to be a standard voluntary disclosure of financial results.

13-01-2026

DENTSPLY SIRONA Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0000818479-26-000024, Size: 786 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, appointment/resignation, or reasons are provided.

13-01-2026

Constellation Energy Corp filed a Form 8-K on January 13, 2026 (AccNo: 0001868275-26-000005, Size: 1 MB), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events, financial statements, or exhibits are disclosed in the provided filing summary. All transaction details, financial metrics, and quantitative data are NOT_DISCLOSED.

13-01-2026

Pelthos Therapeutics Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001753926-26-000097, Size: 926 KB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing indicating a significant transaction likely involving financing or agreements, but no specific details, dollar values, parties, or impacts are disclosed in the provided summary. Sector is not specified.

13-01-2026

Biofrontera Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-001959, Size: 294 KB), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or detailed operational results are provided in the filing summary. Sector is not specified.

13-01-2026

Photronics Inc. disclosed an officer change event via Form 8-K filed on January 13, 2026 (AccNo: 0001140361-26-001053, Size: 189 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), appointment/resignation status, reasons, or named individuals are provided in the filing summary. Sector is not specified.

13-01-2026

SS Innovations International, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001213900-26-003688, size: 21 MB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US SEC. No specific financial metrics, transaction values, or other quantitative details are mentioned.

13-01-2026

Pagaya Technologies Ltd. filed a Form 8-K on January 13, 2026 (AccNo: 0001883085-26-000004, Size: 186 KB) under Item 7.01 for Regulation FD Disclosure. No specific details on the content of the disclosure, transaction, or financial impacts are provided in the filing summary. Sector is not specified.

13-01-2026

TruGolf Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-001958, Size: 198 KB) reporting under Item 8.01 Other Events. Sector is not specified. No details on the specific event, transaction values, financial impacts, or other quantitative data are disclosed in the provided filing summary.

13-01-2026

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001905, Size: 156 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 7.01 Regulation FD Disclosure. This constitutes financial results disclosure from the US market. No specific revenue, earnings, transaction values, or other numerical metrics are mentioned.

13-01-2026

NLIGHT, INC. filed a Form 8-K on January 13, 2026 (AccNo: 0001124796-26-000006, Size: 185 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US market with sector not specified. No specific revenue, earnings, transaction values, or other quantitative financial metrics are mentioned in the filing summary.

13-01-2026

Beeline Holdings, Inc. filed an 8-K on January 13, 2026 (AccNo: 0001493152-26-001957, Size: 226 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with sector not specified. No details on the core event, financials, or exhibits are disclosed in the provided summary.

13-01-2026

AudioEye Inc filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003108, Size: 224 KB) reporting Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). This is a multi-item filing focused on financial results disclosure. No specific financial metrics, transaction values, or other quantitative details are provided in the filing summary.

13-01-2026

IDEXX Laboratories Inc./DE filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003103, Size: 534 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, nature of change (appointment or departure), reasons, or any quantitative data are provided in the summary.

13-01-2026

PureCycle Technologies, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011168, Size: 316 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Trump Media & Technology Group Corp. filed a Form 8-K on January 13, 2026 (AccNo: 0001140361-26-001056, Size: 259 KB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the disclosures, events, transactions, or financial data are provided in the filing summary. Sector not specified.

13-01-2026

Nukkleus Inc. filed an 8-K on January 13, 2026 (AccNo: 0001213900-26-003686), disclosing entry into a material definitive agreement (Item 1.01), completion of acquisition or disposition of assets (Item 2.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on deal structure, parties, valuation, or financial impacts are provided in the filing summary. All quantitative metrics, named entities beyond the filer, and strategic rationales are NOT_DISCLOSED.

13-01-2026

AVITA Medical, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011167), reporting multiple events including entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), results of operations and financial condition (Item 2.02), creation of a direct financial obligation (Item 2.03), and unregistered sales of equity securities (Item 3.02), with exhibits in Item 9.01. This is a multi-item filing with no specific transaction values, financial metrics, or other quantitative details disclosed in the provided summary. Sector is not specified.

13-01-2026

Expion360 Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001903596-26-000008, Size: 231 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item general filing with no specific details on the core event, transaction, or financial impacts provided. Sector is not specified.

13-01-2026

Picard Medical, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001829126-26-000265, Size: 20 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core event, transaction, or financial metrics disclosed in the provided summary. Sector is not specified.

13-01-2026

Precision BioSciences Inc. filed a Form 8-K with the SEC on January 13, 2026 (AccNo: 0001628280-26-001955, Size: 186 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, revenues, earnings, or other quantitative data are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure related to financial results.

13-01-2026

Digital Asset Acquisition Corp. filed an 8-K on January 13, 2026 (AccNo: 0001213900-26-003691, Size: 1 MB) disclosing entry into a Material Definitive Agreement (Item 1.01), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). This pertains to a Merger/Acquisition event in the US market, with sector not specified. No specific parties, deal structure, valuation, or financial metrics are disclosed.

13-01-2026

Moleculin Biotech, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001437749-26-001140, Size: 198 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure, likely sharing material nonpublic information via Reg FD with attached exhibits. No core event details, transaction values, financial metrics, or other specifics are provided in the filing summary.

13-01-2026

Treace Medical Concepts, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011177, Size: 10 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a financial results disclosure event. No specific revenue, earnings, transaction values, or other financial metrics are disclosed in the provided filing summary.

13-01-2026

Aclarion, Inc. filed a Form 8-K on January 13, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided filing summary. This is a multi-item voluntary filing related to Regulation FD.

13-01-2026

NextPlat Corp filed an 8-K on January 13, 2026 (AccNo: 0001437749-26-001144, Size: 266 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason, appointment/resignation, or compensation are provided in the summary. Sector is not specified.

13-01-2026

Coherus Oncology, Inc. filed an 8-K on January 13, 2026 (AccNo: 0001104659-26-003117, Size: 790 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results but no specific revenue, earnings, transaction values, or other metrics are mentioned. Sector not specified.

13-01-2026

Revvity, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0000031791-26-000003, Size: 3 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary.

13-01-2026

Bristow Group Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011199, Size: 301 KB) reporting Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely involving a voluntary disclosure under Regulation FD with attached exhibits. No core event details, financial metrics, transactions, or quantitative data are specified.

13-01-2026

Royal Gold Inc filed a Form 8-K on January 13, 2026 (AccNo: 0000085535-26-000002, size: 256 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results as a routine earnings-related filing. No specific revenue, earnings, transaction values, or other metrics are mentioned.

13-01-2026

Illumina, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001110803-26-000009, Size: 263 KB), reporting under Item 2.02 for Results of Operations and Financial Condition. Item 9.01 includes Financial Statements and Exhibits. No specific revenue, earnings, transaction values, or other financial metrics are disclosed in the filing summary.

13-01-2026

Fortress Biotech, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003121), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative data, named entities beyond the filer, and event specifics are NOT_DISCLOSED.

13-01-2026

Vericel Corp filed a Form 8-K on January 13, 2026 (AccNo: 0001140361-26-001060, Size: 199 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction details, or quantitative data are provided in the filing summary.

13-01-2026

Intuitive Machines, Inc. filed an 8-K on January 13, 2026 (AccNo: 0001193125-26-011200, Size: 467 KB), disclosing entry into a material definitive agreement (Item 1.01), completion of acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on deal structure, parties involved, valuation, consideration, or strategic rationale are provided in the filing summary. All quantitative metrics such as transaction value, share counts, and financial impacts are NOT_DISCLOSED.

13-01-2026

Castle Biosciences Inc filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001909, Size: 1 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a financial results disclosure event. No specific revenue, earnings, transaction values, or other quantitative financial metrics are disclosed in the provided filing summary.

13-01-2026

RCI Hospitality Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001922, Size: 204 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, transaction values, or other quantitative details are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Lion Copper & Gold Corp. filed a Form 8-K on January 13, 2026 (AccNo: 0001062993-26-000210, Size: 216 KB), reporting Item 3.02: Unregistered Sales of Equity Securities. This appears to be a single-item mandatory disclosure with no specific details on transaction value, share count, parties, or financial impact provided in the filing summary. Sector not specified.

13-01-2026

FIVE STAR BANCORP filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001931, Size: 300 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on the core event, transaction, financial impacts, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Dogwood Therapeutics, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003211, Size: 1 MB), reporting entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific transaction details, values, counterparties, or financial metrics are disclosed in the provided summary. This is a multi-item mandatory filing as a material event.

13-01-2026

AB International Group Corp. filed a Form 8-K on January 13, 2026 (AccNo: 0001663577-26-000011, Size: 382 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing related to a core event involving a material agreement with financial and equity components. No specific transaction values, terms, or financial metrics are disclosed in the provided information.

13-01-2026

Strive, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001928, Size: 350 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Co-Diagnostics, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-001971, Size: 200 KB) under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing. No specific details on the delisting reason, transaction value, financial impacts, or other metrics are disclosed. Sector is not specified.

13-01-2026

Aircastle LTD filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001935, Size: 372 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure from the US market. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary.

13-01-2026

Black Spade Acquisition III Co filed an 8-K on January 13, 2026 (AccNo: 0001104659-26-003253, Size: 155 KB), announcing a merger/acquisition under Item 8.01 Other Events, with Item 9.01 Financial Statements and Exhibits. No details on deal structure, parties involved, valuation, or financial metrics are explicitly stated in the provided filing summary. Sector is not specified.

13-01-2026

Lakeland Financial Corp filed a Form 8-K on January 13, 2026 (AccNo: 0000721994-26-000003, Size: 174 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided filing information. This appears to be a voluntary disclosure under Regulation FD with attached exhibits.

13-01-2026

AMERICAN REBEL HOLDINGS INC filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-001991, Size: 2 MB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.02 (Departure of Directors/Officers or Compensatory Arrangements), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, share counts, or named entities disclosed in the provided summary. Sector not specified.

13-01-2026

ACADIA PHARMACEUTICALS INC filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011706, Size: 163 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or other quantitative data are disclosed in the provided filing summary.

13-01-2026

ALPHA MODUS HOLDINGS, INC. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-002012, Size: 251 KB) under Item 7.01 for Regulation FD Disclosure. No specific details, events, transactions, financial metrics, or named entities beyond the filer are disclosed in the provided filing summary. Sector not specified.

13-01-2026

Ohio Valley Banc Corp filed a Form 8-K on January 13, 2026, under Item 8.01 Other Events. The filing has accession number 0000894671-26-000002 and size of 147 KB. No specific details on the event, transaction, financial impacts, or other quantitative data are disclosed in the provided filing summary.

13-01-2026

Onfolio Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001654954-26-000330, Size: 184 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

13-01-2026

Horizon Space Acquisition II Corp. filed an SEC document on January 13, 2026 (AccNo: 0001213900-26-003872, Size: 21 MB) related to a Merger/Acquisition event. No specific details on deal structure, parties involved, valuation, or strategic rationale are disclosed in the provided information. Sector is not specified.

13-01-2026

Advance Auto Parts Inc filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001962, Size: 439 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), appointment/resignation status, reasons, or quantitative data are disclosed in the provided filing summary. Sector not specified.

13-01-2026

Clene Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001437749-26-001196, Size: 965 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing for material events, but specific details of the agreement, events, or exhibits are NOT_DISCLOSED. No quantitative financial data, transaction values, or named counterparties are provided.

13-01-2026

Guardian Pharmacy Services, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011826, Size: 4 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results with no specific numerical data, transaction details, or strategic information provided in the filing summary. Sector is not specified.

13-01-2026

Scorpius Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001079973-26-000077, Size: 388 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory disclosure of material events. No transaction values, share counts, or other quantitative details are provided in the filing summary.

13-01-2026

Broadcom Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011731, Size: 613 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, or exhibits are disclosed in the provided filing summary. Sector not specified.

13-01-2026

Solitron Devices Inc filed a Form 8-K on January 13, 2026 (AccNo: 0001437749-26-001187, Size: 246 KB), disclosing Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results with no specific numerical financial metrics, transaction values, or other quantitative details provided in the summary. Sector is not specified.

13-01-2026

Greenlane Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-002030, size 569 KB), reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No details on the agreement's terms, parties, value, or financial impacts are provided in the summary.

13-01-2026

Tamboran Resources Corp filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001952, Size: 14 MB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or compensation arrangements are disclosed in the provided information. Sector is not specified.

13-01-2026

Phoenix Education Partners, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011725, Size: 714 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Transportation & Logistics Systems, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-002029, Size: 277 KB), disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, counterparties, or financial impacts are provided in the filing summary. Sector is not specified.

13-01-2026

PARK AEROSPACE CORP filed an 8-K on January 13, 2026 (AccNo: 0001437749-26-001183, Size: 472 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

N2OFF, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-002031, Size: 344 KB), disclosing under Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction size, parties involved, or financial impacts are provided in the summary. Sector is not specified.

13-01-2026

Rocky Mountain Chocolate Factory, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001437749-26-001186, Size: 382 KB) reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results, but no specific revenue, earnings, transaction values, or other metrics are provided in the filing summary. Sector is not specified.

13-01-2026

Clearway Energy, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003322, Size: 1 MB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No details on transaction value, parties, terms, or financial metrics are provided in the summary.

13-01-2026

EPAM Systems, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001352010-26-000005, Size: 172 KB) under Item 7.01 Regulation FD Disclosure. No details on the specific disclosure content, events, transactions, or financial metrics are provided in the available filing summary. Sector is not specified.

13-01-2026

GlauKos Corp filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003321, Size: 5 MB) under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, transaction values, or other quantitative metrics are mentioned. Sector is not specified.

13-01-2026

ALPHATIME ACQUISITION CORP filed an 8-K on January 13, 2026 (AccNo: 0001493152-26-002017, Size: 271 KB), disclosing under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. This is presented as a Merger/Acquisition event with no specific details on parties, structure, valuation, or synergies provided. Sector is not specified.

13-01-2026

byNordic Acquisition Corp filed an 8-K on January 13, 2026 (AccNo: 0001213900-26-003902, Size: 259 KB), disclosing a merger/acquisition event under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on deal structure, parties involved, valuation, or financial metrics are provided in the filing summary. Sector not specified; all transaction specifics NOT_DISCLOSED.

13-01-2026

B. Riley Financial, Inc. filed an 8-K on January 13, 2026 (AccNo: 0001213900-26-003901), disclosing under Item 2.01 the completion of an acquisition or disposition of assets. Item 9.01 provides financial statements and exhibits. No details on parties involved, deal structure, valuation, or strategic rationale are explicitly stated.

13-01-2026

Farmers National Banc Corp /OH/ filed an 8-K on January 13, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). AccNo: 0001193125-26-011710, file size 194 KB. No specific events, transactions, financial metrics, or numerical values are disclosed in the provided filing summary.

13-01-2026

Art Technology Acquisition Corp. filed an 8-K on January 13, 2026 (AccNo: 0001213900-26-003895, Size: 442 KB) disclosing a Merger/Acquisition under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on deal structure, parties involved, valuation, terms, or financial metrics are provided in the filing summary. Sector is not specified.

13-01-2026

Impinj Inc filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011765, Size: 196 KB) disclosing results of operations and financial condition under Item 2.02 and financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative results are provided in the filing summary. This appears to be a standard earnings-related disclosure without detailed data available.

13-01-2026

Grocery Outlet Holding Corp. filed an 8-K on 2026-01-13 (AccNo: 0001771515-26-000004, Size: 446 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer involved, position affected, nature of change (appointment/resignation), reasons, or quantitative data provided.

13-01-2026

Confluent, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003336, Size: 203 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Envirotech Vehicles, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001437749-26-001193, Size: 157 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impacts, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

CF Industries Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003338, Size: 291 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details such as the affected officer's position, whether it is an appointment or resignation, reasons for the change, or any quantitative data are NOT_DISCLOSED. Sector is not specified.

13-01-2026

RAPID MICRO BIOSYSTEMS, INC. filed a Form 8-K on January 13, 2026 (AccNo: 0001380106-26-000007, size 169 KB) disclosing financial results under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results event. No specific revenue, earnings, transaction values, or other quantitative financial metrics are mentioned.

13-01-2026

ADAMAS TRUST, INC. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003334, Size: 702 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are provided. Sector not specified.

13-01-2026

Concrete Pumping Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001437749-26-001190, Size: 920 KB), reporting results of operations and financial condition under Item 2.02 and financial statements and exhibits under Item 9.01. This is a standard financial results disclosure with no specific revenue, earnings, or other quantitative metrics detailed in the provided filing summary. Sector is not specified.

13-01-2026

Target Hospitality Corp. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003335, Size: 337 KB), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections or appointments of directors/officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer involved, position, reason for change, or quantitative data were provided.

13-01-2026

TELEPHONE & DATA SYSTEMS INC /DE/ filed an 8-K on January 13, 2026 (AccNo: 0001051512-26-000002, Size: 248 KB) under Item 2.01 announcing the completion of an acquisition or disposition of assets and Item 8.01 for other events. No details on parties involved, deal structure, valuation, strategic rationale, or financial metrics are disclosed. Sector is not specified.

13-01-2026

INSPIRE VETERINARY PARTNERS, INC. filed a Form 8-K on January 13, 2026 (AccNo: 0001213900-26-003919, Size: 2 MB), reporting under Item 5.03 amendments to Articles of Incorporation or Bylaws or a change in fiscal year, and under Item 9.01 financial statements and exhibits. No details on the specific amendments, changes, or exhibits are disclosed in the provided summary. This is a multi-item general filing from the US SEC with sector not specified.

13-01-2026

Willow Lane Acquisition Corp. filed an 8-K on January 13, 2026 (AccNo: 0001493152-26-002040), disclosing under Item 1.01 entry into a Material Definitive Agreement related to a merger/acquisition, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific details on parties, deal structure, valuation, or financial metrics are disclosed. Sector is not specified.

13-01-2026

Procter & Gamble Co filed a Form 8-K on January 13, 2026 (AccNo: 0000080424-26-000002, Size: 401 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the disclosure or exhibits are provided. Sector not specified.

13-01-2026

AirJoule Technologies Corp. filed a Form 8-K on January 13, 2026 (AccNo: 0001213900-26-003985, Size: 255 KB), disclosing under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). Sector not specified. No specific financial metrics, transaction details, or quantitative data provided in the filing summary.

13-01-2026

Cytek Biosciences, Inc. filed an 8-K on January 13, 2026 (AccNo: 0001193125-26-011748, Size: 156 KB) under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure. No specific financial metrics, transaction values, or other quantitative details are mentioned.

13-01-2026

ARRAY DIGITAL INFRASTRUCTURE, INC. filed an 8-K on January 13, 2026 (AccNo: 0000821130-26-000003, Size: 634 KB) disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing also reports other events under Item 8.01 and includes financial statements and exhibits under Item 9.01. All specific details on deal structure, parties, valuation, and terms are NOT_DISCLOSED.

13-01-2026

FIRST BUSEY CORP /NV/ filed a General Filing (Form 8-K) on January 13, 2026, under Item 8.01 Other Events. The filing has Accession Number 0000314489-26-000003 and a file size of 313 KB. No specific details on the event, transaction, or financial impacts are disclosed in the provided summary.

13-01-2026

TG Therapeutics, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001437749-26-001194, Size: 215 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the Regulation FD disclosure content or exhibits are provided in the filing summary. Sector not specified.

13-01-2026

Victory Capital Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011816, size 363 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific event details, transaction values, or financial metrics disclosed in the provided summary. Sector is not specified.

13-01-2026

Semler Scientific, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003354, size: 170 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on matters submitted, vote results, or outcomes are disclosed in the provided filing summary. This appears to be a standard post-shareholder meeting disclosure.

13-01-2026

Myseum, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001213900-26-003936, Size: 263 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, financial statements, or exhibits are provided in the filing summary. Sector is not specified.

13-01-2026

Aspire Biopharma Holdings, Inc. disclosed an officer change via Form 8-K filed on January 13, 2026 (AccNo: 0001493152-26-002057, Size: 252 KB) under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the available information. Sector is not specified.

13-01-2026

Travere Therapeutics, Inc. filed a Form 8-K on January 13, 2026, reporting under Item 8.01 Other Events. Accession number: 0001438533-26-000005; file size: 161 KB. No details on the specific event, transaction, or financial implications are disclosed.

13-01-2026

GULF ISLAND FABRICATION INC filed a Form 8-K on January 13, 2026 (AccNo: 0001140361-26-001103, Size: 187 KB), reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, numerical values, transaction sizes, or outcomes are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

TTM Technologies Inc filed a Form 8-K on January 13, 2026, under Item 7.01 Regulation FD Disclosure. The filing has accession number 0001193125-26-011807 and size of 140 KB. No additional details on the disclosure content, events, or financial metrics are provided.

13-01-2026

YIJIA GROUP CORP. filed a Form 8-K on January 13, 2026 (AccNo: 0001683168-26-000259, size: 3 MB), reporting under Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the amendments, events, financial statements, or exhibits are provided. Sector is not specified.

13-01-2026

CG Oncology, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011855, Size: 160 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative financial data, core events, and impacts are NOT_DISCLOSED.

13-01-2026

Aviat Networks, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001978, Size: 4 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event details, transaction values, financial metrics, or other specific content are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Denny's Corp filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011802), reporting under Item 5.07: Submission of Matters to a Vote of Security Holders. No specific vote results, proposals, numerical data, or other details are disclosed in the provided filing information. This is a standard mandatory disclosure following a shareholder meeting.

13-01-2026

Mountain Lake Acquisition Corp. filed an 8-K on January 13, 2026 (AccNo: 0001213900-26-003955, Size: 1 MB), disclosing under Item 1.01 entry into a material definitive agreement related to a merger/acquisition event. Item 9.01 includes financial statements and exhibits. No specific details on parties, structure, valuation, or terms are explicitly stated in the provided filing summary; sector not specified.

13-01-2026

Kaiser Aluminum Corp filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011824, Size: 263 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial impacts, or quantitative metrics are disclosed in the provided filing summary. Sector not specified.

13-01-2026

Camping World Holdings, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001104659-26-003406, Size: 2 MB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific event details, transaction values, financial metrics, or other quantitative data are disclosed in the provided filing summary. Sector not specified.

13-01-2026

Nuvve Holding Corp. filed a Form 8-K on January 13, 2026, reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Accession Number: 0001836875-26-000010, File Size: 186 KB. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary.

13-01-2026

Israel Acquisitions Corp filed an 8-K on January 13, 2026 (AccNo: 0001104659-26-003402, Size: 256 KB), disclosing Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, and Item 9.01 Financial Statements and Exhibits. No details on merger/acquisition structure, parties, valuation, or strategic rationale are provided. Sector not specified.

13-01-2026

Crinetics Pharmaceuticals, Inc. filed an 8-K on January 13, 2026 (AccNo: 0001193125-26-011872, Size: 6 MB) reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or other quantitative details are mentioned.

13-01-2026

Pearl Diver Credit Co Inc. filed a Form 8-K on January 13, 2026, under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Accession Number: 0001214659-26-000444, file size: 237 KB.

13-01-2026

Energy Fuels Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001062993-26-000229, size: 13 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

13-01-2026

Belden Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011887, size 178 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the core event, transaction, financial impacts, or exhibits are provided in the filing summary. All quantitative data, named entities, and strategic implications are NOT_DISCLOSED.

13-01-2026

Cineverse Corp. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011867, Size: 219 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, or financials are disclosed in the provided filing summary. Sector is not specified.

13-01-2026

Laser Photonics Corp disclosed an officer change via Form 8-K filed on January 13, 2026 (AccNo: 0001493152-26-002077, Size: 203 KB). The filing references Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, reason, or compensation provided.

13-01-2026

SKYX Platforms Corp. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-002076, Size: 385 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided information. Sector is not specified.

13-01-2026

Avanos Medical, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001628280-26-001991, Size: 3 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the content of the disclosures, events, transactions, financial metrics, or exhibits are provided in the filing summary. This appears to be a multi-item voluntary filing related to Regulation FD information.

13-01-2026

MAIA Biotechnology, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001493152-26-002085, Size: 12 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with no specific event details, transaction values, or financial metrics disclosed in the provided summary. Sector is not specified.

13-01-2026

Red Violet, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001193125-26-011891, Size: 279 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on positions affected, individuals involved, reasons, or compensation are provided. Sector is not specified.

13-01-2026

Estrella Immunopharma, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0001213900-26-003998, Size: 241 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. This discloses a delisting event from the US market. Sector not specified.

13-01-2026

Chefs' Warehouse, Inc. filed a Form 8-K on January 13, 2026 (AccNo: 0000947871-26-000031, Size: 235 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item general filing from the US SEC with no specific event details, transaction values, or financial metrics disclosed in the provided summary.